Boardroom Alpha
Boardroom Alpha
APP · Current Report (Form 8-K) · Filed July 1, 2025

Applovin Corp — Current Report (Form 8-K)

Form
8-K
Filed
July 1, 2025
Period
Jun 30, 2025
Ticker
APP
Accession
0001751008-25-000061
Boardroom Alpha · Filing insights

Amendment allows cash funding instead of a promissory note; closing delivered $400M cash and ~20% equity to Purchasers.

About Applovin Corp
Market cap
$206.2B
1Y TSR
+34.9%
3Y TSR
+175.8%
Board grade
B+
Sector
Technology
CEO
Arash Adam Foroughi
Last annual meeting: Jun 3, 2026 · View full Applovin Corp profile →
app-20250630

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 30, 2025 
AppLovin Corporation
(Exact name of registrant as specified in its charter)
Delaware001-4032545-3264542
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1100 Page Mill Road
Palo Alto, California 94304
(Address of principal executive offices, including zip code)
(800) 839-9646
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Class A common stock, par value $0.00003 per share APP The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 1.01    Entry into a Material Definitive Agreement

On June 30, 2025, AppLovin Corporation (“AppLovin”) and Tripledot (“Purchaser Parent”) entered into an amendment (the “Amendment”) to that certain Purchase Agreement, dated as of May 7, 2025 by and among AppLovin, its subsidiaries Morocco, Inc. and AppLovin GmbH (collectively with AppLovin, the “Sellers”), Purchaser Parent, and its subsidiaries Eton Games, Inc. (“Eton”) and Tripledot Group Holdings Limited (collectively, with Purchaser Parent, the “Purchasers”), (as amended, the “Purchase Agreement”, and the transactions contemplated thereby, the “Transactions”) to provide, among other things, that in lieu of the issuance of a secured promissory note by Eton to AppLovin or its designated affiliate at the closing of the Transactions (the “Closing”) to fund a portion of the full Cash Consideration (as defined in the Purchase Agreement), Purchaser Parent may elect to pay such amount in cash.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit 2.1, and the terms of which are incorporated herein by reference.

Item 8.01    Other Events

On June 30, 2025, AppLovin and the Sellers completed the Closing under the Purchase Agreement. At Closing, AppLovin transferred the equity interests of certain of its wholly owned subsidiaries that are engaged in AppLovin’s mobile gaming business to the Purchasers for consideration consisting of (i) $400.0 million in cash consideration, subject to closing adjustments, and (ii) equity consideration comprised of ordinary shares of Purchaser Parent representing approximately 20% of the fully-diluted equity capitalization of Purchaser Parent at the time of the Closing. No promissory note was issued as part of the purchase consideration.

Item 9.01    Financial Statements and Exhibits
(d) Exhibits:
Exhibit No. Exhibit Description
2.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).






SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
APPLOVIN CORPORATION
Date: July 1, 2025/s/ Matthew A. Stumpf
Matthew A. Stumpf
Chief Financial Officer


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Applovin Corp (APP)

Reference

Frequently asked questions

When did Applovin Corp file this 8-K?
Applovin Corp (APP) filed this Current Report (Form 8-K) with the SEC on July 1, 2025. The accession number assigned by EDGAR is 0001751008-25-000061.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Amendment allows cash funding instead of a promissory note; closing delivered $400M cash and ~20% equity to Purchasers. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Applovin Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Applovin Corp has filed under CIK 1751008, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer